Taiwan FDA registration 06f900b7256170a2aa7fb7c6e2c0a928
"Sindis" new generation of Xinkeji intervertebral stent implant
TW: “信迪思”新一代辛凱吉椎間支架植入物
Taiwan·Risk Class 2·SYNTHES GMBH;; Jabil Switzerland Manufacturing GmbH·Registered Apr 19, 2019 – Apr 19, 2029ActiveRegistration details
- Analysis ID
- 06f900b7256170a2aa7fb7c6e2c0a928
- Customs Code
- DHA05603251909
Company information
- Manufacturer Country
- Switzerland
- Authorized Representative
- JOHNSON & JOHNSON MEDICAL TAIWAN LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- N Orthopedics
- Product Type (Level 2)
- N.3080 椎體間融合裝置
- Import Information
- Input;; Contract manufacturing
Dates and status
- Registration Date
- Apr 19, 2019
- Expiry Date
- Apr 19, 2029
About this record
Access comprehensive regulatory information for "Sindis" new generation of Xinkeji intervertebral stent implant in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 06f900b7256170a2aa7fb7c6e2c0a928 and manufactured by SYNTHES GMBH;; Jabil Switzerland Manufacturing GmbH. The authorized representative in Taiwan is JOHNSON & JOHNSON MEDICAL TAIWAN LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices